Index Performance
-7.13%
SCDI
+1.38%
IBB
+6.86%
DIA
+3.27%
QQQ
Overview
Description
To track the performance of clinical development organizations.
- TickerSCDI
- Inception Date05/31/2023
- WeightingEqual
- # of holdings12
What's inside?
Holdings
All holdings as of October 18, 2024
CSV download
Bio-Rad Laboratories, Inc. (BIO) | 9.15% | $9.71B | -6.26% | 55.71% | 2.94 |
Veeva Systems, Inc. (VEEV) | 8.98% | $35.84B | 14.56% | 74.80% | 10.40 |
ICON plc (ICLR) | 8.56% | $24.66B | 4.95% | 22.49% | 3.51 |
Thermo Fisher Scientific, Inc. (TMO) | 8.55% | $229.85B | -1.37% | 41.21% | 5.63 |
IQVIA Holdings, Inc. (IQV) | 8.52% | $43.15B | 2.53% | 27.71% | 3.35 |
Medpace Holdings, Inc. (MEDP) | 8.49% | $11.05B | 14.59% | 27.76% | 6.33 |
Charles River Laboratories International, Inc. (CRL) | 8.37% | $10.21B | -3.19% | 32.69% | 3.29 |
West Pharmaceutical Services, Inc. (WST) | 8.29% | $21.28B | -6.92% | 32.95% | 8.39 |
Evotec SE (EVO) | 8.28% | $1.12B | 5.80% | 8.64% | 2.22 |
Harvard Bioscience, Inc. (HBIO) | 7.83% | $107.72M | -19.69% | 51.47% | 1.60 |
CryoPort, Inc. (CYRX) | 7.73% | $373.06M | 1.01% | 36.27% | 1.55 |
Fortrea Holdings, Inc. (FTRE) | 7.25% | $1.78B | -16.47% | 17.47% | 1.10 |
Market data by FactSet